Bronchospasm Global Clinical Trials Review, H1, 2012

GlobalData, March 2012, Pages: 57

Bronchospasm Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2012" provides data on the Bronchospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bronchospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Bronchospasm Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Bronchospasm , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Bronchospasm
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Bronchospasm
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Bronchospasm Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Amphastar Pharmaceuticals, Inc.
Clinical Trial Overview of Amphastar Pharmaceuticals, Inc.
Mylan Inc.
Clinical Trial Overview of Mylan Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sunovion Pharmaceuticals Inc.
Clinical Trial Overview of Sunovion Pharmaceuticals Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The Ohio State University
Clinical Trial Overview of The Ohio State University
University of New Mexico
Clinical Trial Overview of University of New Mexico
Royal Melbourne Hospital
Clinical Trial Overview of Royal Melbourne Hospital
Medisch Spectrum Twente
Clinical Trial Overview of Medisch Spectrum Twente
The University of Arizona
Clinical Trial Overview of The University of Arizona
University Hospital of Larissa
Clinical Trial Overview of University Hospital of Larissa
Centre Hospitalier Universitaire de Saint Etienne
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
Bispebjerg Hospital
Clinical Trial Overview of Bispebjerg Hospital
Indiana University School of Medicine
Clinical Trial Overview of Indiana University School of Medicine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Bronchospasm Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Bronchospasm Therapeutics Clinical Trials, Europe, Top Countries, 2012-
Bronchospasm Therapeutics Clinical Trials, North America, Top Countries, 2012-
Bronchospasm Therapeutics Clinical Trials, G7 Countries, 2012-
Bronchospasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Bronchospasm Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Bronchospasm Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Bronchospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Amphastar Pharmaceuticals, Inc., 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunovion Pharmaceuticals Inc., 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Melbourne Hospital, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Medisch Spectrum Twente, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2012-
Bronchospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2012-

List of Figures
Bronchospasm Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Bronchospasm Therapeutics Clinical Trials, Europe, Top Countries (%), 2012-
Bronchospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Bronchospasm Therapeutics Clinical Trials, G7 Countries (%), 2012-
Bronchospasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Bronchospasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Bronchospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Bronchospasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Bronchospasm Global Clinical Trials Review, H1, 2013
• Bronchospasm Global Clinical Trials Review, Q1, 2011
• Bronchitis Global Clinical Trials Review, H2, 2012
• Cholangitis Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Keratitis Global Clinical Trials Review, H2, 2012
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Hemostasis Global Clinical Trials Review, H1, 2013